menu icon

Univercells
Powering Biotech
Innovation

A holding company enabling the success of our four commercial businesses.

About Us

arrow right

What is Univercells?

What is Univercells?
What is Univercells?

Univercells is a biotech-focused holding company. We empower our businesses—Quantoom, Exothera, Unizima, and RLM—to transform how biotech drugs are made and delivered. Through innovation, expertise, and strategic vision, we enable scalable and sustainable solutions for global health.

What We Do

arrow right

Key figures 2023

Countries using our projects and products

+

Technologies under development

Installed base of RNA technologies

Sites across Europe and US

Join a diverse team of innovators

img-1
img-1
img-1

We are a diverse team of scientists, entrepreneurs, operators, strategists, communicators - all driven to make sure that everyone, everywhere, has access to biotech drugs.

Join Us

arrow right

Latest news

See All arrow right
news img

November 29, 2024

Belgium and Brazil Unite to Advance RNA-Based Therapies: MoU Signed Between Bio-Manguinhos/Fiocruz, Quantoom Biosciences, and Univercells in the presence of Her Royal Highness Princess Astrid of Belgium during the Belgian Economic Mission to Brazil

news img

November 22, 2024

Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian Biotech Innovator, Univercells.

news img

April 10, 2024

Press Release: Serum Institute of India Collaborates with Univercells to bring Affordable Personalized Oncology to Masses

news img

March 25, 2024

Press Release: Altamira Therapeutics announces collaboration with Univercells Group on Nanoparticle-Delivered mRNA vaccines.

news img

March 21, 2024

Press Release: Univercells and the Government of the Federal Republic of Nigeria signed a MoU focusing on building a thriving biopharmaceutical ecosystem in Nigeria and upskilling its workforce to increase local manufacturing.